Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Revenue

Handa Pharmaceuticals had revenue of 215.53M TWD in the quarter ending June 30, 2024, a decrease of -8.29%. This brings the company's revenue in the last twelve months to 972.97M, up 34.58% year-over-year. In the year 2023, Handa Pharmaceuticals had annual revenue of 1.11B with 459.66% growth.

• Revenue (ttm): 972.97M
• Revenue Growth: +34.58%
• P/S Ratio: 11.90
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 11.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.11B	908.64M	459.66%
Dec 31, 2022	197.68M	168.44M	576.16%
Dec 31, 2021	29.24M	376.00K	1.30%
Dec 31, 2020	28.86M	-55.21M	-65.67%
Dec 31, 2019	84.07M	-9.62M	-10.27%